The Anti-Inflammatory Infusion is a physician-prescribed combination IV for inflammatory pain flares. It pairs IV-route ketorolac (Toradol) — a fast-acting injectable NSAID and the component with the clearest anti-inflammatory effect — with glutathione, vitamin C, and magnesium, which are added for their antioxidant and supportive roles. At Modal Pain Management NYC, the infusion is prescribed and monitored by Dr. Alex Movshis, a board-certified anesthesiologist and interventional pain specialist, which is the appropriate level of medical oversight for a therapy that includes a prescription NSAID.
Why an IV Anti-Inflammatory Infusion (vs. Oral NSAIDs)
Oral NSAIDs like ibuprofen and naproxen work well for mild to moderate inflammatory pain. Their limits are speed and practicality. They take longer to kick in, absorption is slowed by food and nausea, and some patients can’t keep pills down during a bad flare. IV ketorolac (Toradol) skips the gut, usually starts working within about 30 minutes, and gives a predictable dose. It does not skip the risks. Ketorolac affects the kidneys, the stomach lining and platelets the same way oral NSAIDs do, because those effects come from blocking COX enzymes throughout the body. IV delivery makes the most sense for an acute flare, soreness after a procedure, severe musculoskeletal pain, or nausea that makes pills impractical.
The infusion does not stop at Toradol. The combination with glutathione, vitamin C, and magnesium is intended to act on pathways NSAIDs alone do not — oxidative stress and muscle/vascular tension. We should be candid that the anti-inflammatory benefit of the antioxidant components is not established in humans. The NSAID does the proven anti-inflammatory work.
Clinical Applications
Dr. Movshis prescribes the Anti-Inflammatory Infusion for a few specific situations, not as a generic “wellness drip”:
- Post-procedural recovery. Patients recovering from interventional procedures — epidural steroid injections, genicular nerve RFA, or muscle and tendon injections other than PRP — sometimes use a single infusion in the first few days for post-procedure soreness. This is for comfort. It has not been shown to change the result of the procedure. The infusion contains ketorolac, an NSAID, so it is not given within 2 weeks before or 2 weeks after a PRP injection.
- Acute musculoskeletal flares. For patients with chronic conditions like knee osteoarthritis, hip osteoarthritis, shoulder bursitis, or SI joint dysfunction having an acute flare, a one-off infusion can take the edge off while the flare settles, which can make it easier to keep up with physical therapy.
- Severe migraine and headache. IV ketorolac is one of the treatments the 2025 American Headache Society emergency-department guideline says should be offered for a migraine attack (Robblee et al., 2025). The added benefit of magnesium is less certain. Patients with migraine should look at our Migraine Relief IV, which is built for that problem.
- Soft-tissue injuries. Acute strains, sprains and overuse flares (including tennis elbow, plantar fasciitis, and knee bursitis) can hurt less with short-term NSAID use. For long-standing tendon problems, an infusion buys comfort, not healing.
- Chronic inflammatory pain syndromes. For patients managing diffuse inflammatory pain alongside their interventional pain plan, an occasional infusion during a flare can serve as an adjunct. Repeated NSAID doses add up, so infusions are spaced out and reviewed.
The infusion is not a substitute for definitive interventional care for structural pain (a degenerated disc, a torn meniscus, or chronic facet arthropathy), and Dr. Movshis will recommend the appropriate procedural pathway when indicated — see our conditions and treatments directories.
Mechanism — How Each Ingredient Works
Toradol (ketorolac) is a non-selective COX-1 / COX-2 inhibitor that blocks the production of prostaglandins, the principal mediators of inflammatory pain, swelling, and tissue sensitization. It treats moderate to severe pain without the sedation, breathing suppression or addiction risk of opioids. According to its FDA label, pain relief after an IV dose begins in about 30 minutes, peaks at 1–2 hours and lasts 4–6 hours. The same label limits ketorolac to 5 days of use in total and says it is meant for short-term, moderately severe acute pain, not for minor or chronic painful conditions. That is why it is used here only for flares and short-lived pain such as post-procedure soreness. The label also carries boxed warnings about stomach bleeding, kidney injury, bleeding risk and cardiovascular events, which is why every patient is screened first.
Glutathione is a tripeptide (glutamate-cysteine-glycine) and one of the main antioxidants inside cells. It neutralizes reactive oxygen species and helps recycle vitamins C and E. Oral glutathione is poorly absorbed, which is the argument for giving it by vein. What has not been shown is that IV glutathione reduces inflammation or pain in people. A small randomized, placebo-controlled pilot of IV glutathione in Parkinson’s disease found no significant difference from placebo (Hauser et al., 2009).
Vitamin C (ascorbic acid) given by vein reaches much higher blood levels than the gut allows. At the same dose, IV vitamin C produced peak blood levels about six to seven times higher than oral, and the gap widens as the IV dose goes up (Padayatty et al., 2004). Vitamin C is an antioxidant and a cofactor for collagen synthesis. Whether higher blood levels reduce pain or inflammation in people has not been shown.
Magnesium blocks NMDA receptors, part of the pathway behind central sensitization in chronic pain, and relaxes smooth muscle. Those mechanisms are why it shows up in pain and migraine protocols. Its clinical benefit as an add-on is modest and inconsistent. For acute migraine, for example, a meta-analysis of randomized trials found no reliable benefit from IV magnesium (Choi & Parmar, 2014).
Candidate Selection
Good candidates for the Anti-Inflammatory Infusion include patients with an acute inflammatory pain flare who need faster relief than oral NSAIDs give or can’t keep pills down, soreness after an interventional pain procedure, a chronic inflammatory pain condition where oral anti-inflammatory therapy has been inadequate or poorly tolerated, a severe musculoskeletal flare, or a recent soft-tissue injury.
The infusion is not appropriate for patients with active gastrointestinal bleeding or peptic ulcer disease, reduced kidney function, dehydration or acute kidney injury, a documented NSAID allergy or asthma with NSAID-induced bronchospasm, active bleeding or a blood thinner that rules out an NSAID, recent heart bypass surgery, another NSAID or aspirin already taken that day, pregnancy or breastfeeding without OB clearance, known G6PD deficiency, or an iron-overload disorder. Dr. Movshis screens every patient with a focused medical history and relevant lab review before the first infusion.
What to Expect
Your first visit begins with a focused medical history, medication review, and brief physical exam to confirm that the infusion is appropriate and to identify any contraindications. The infusion itself is administered in a private treatment room over approximately 45 minutes. You’ll be seated comfortably with vital-signs monitoring throughout. Most patients feel more comfortable as the infusion goes in. Toradol’s effect is usually noticeable within about 30 minutes. Some patients feel warmth or flushing during the drip, which passes on its own. After the infusion, you can return to normal activities immediately — there are no driving restrictions, no sedation, and no recovery period beyond the infusion itself.
Recommended Treatment Schedule
For an acute flare or post-procedural inflammation, a single infusion is often all that is needed. For chronic inflammatory conditions or recurrent flares, Dr. Movshis may recommend a short series of 3–4 weekly infusions followed by occasional sessions, with the cumulative dosing reviewed at each visit. Because IV ketorolac shares the kidney and stomach risks of all NSAIDs, and its label limits any course to 5 days, the schedule is set conservatively. Many of our chronic-pain patients schedule the infusion to coincide with a follow-up visit or as part of their post-procedural recovery plan.
Safety and Important Considerations
Consult Dr. Movshis before treatment if you have kidney disease or reduced kidney function, active gastrointestinal ulceration or bleeding, are pregnant or breastfeeding, have hereditary iron overload (hemochromatosis), have asthma with NSAID sensitivity, are on anticoagulation, or have G6PD deficiency. Patients on routine antihypertensives, ACE inhibitors, or diuretics should also disclose all medications because NSAIDs can interact with these classes. The infusion is administered with vital-signs monitoring and immediate physician availability — if you experience chest tightness, significant nausea, or any unusual sensation during the infusion, the rate is adjusted or the infusion is paused.
If You Cannot Take an NSAID
Ketorolac is the component of this infusion that carries the most medical weight, and it is also the component some patients cannot receive. If you have kidney impairment, a history of GI bleeding or ulceration, are on anticoagulation, have asthma with NSAID sensitivity, or have a documented NSAID allergy, tell Dr. Movshis before booking. For patients who can’t take ketorolac, the infusion can be given without it, leaving the glutathione, vitamin C and magnesium. The ketorolac-free version is offered only to those patients. Vitamin C has cautions of its own. Tell Dr. Movshis about G6PD deficiency, and kidney disease or a history of kidney stones needs a careful look first.
We want to be straightforward about what that trade-off means. Removing the NSAID removes the part of the infusion with the strongest evidence behind it for inflammatory pain. The antioxidant-only version is a reasonable supportive option, but it is not an equivalent substitute, and for many NSAID-contraindicated patients a targeted procedure — a nerve block, a joint or soft-tissue injection, or radiofrequency ablation — is the better answer than any infusion. Dr. Movshis will tell you which applies to your case rather than defaulting you into a drip.
Cost and Booking
The Anti-Inflammatory Infusion is offered from $200 per session at Modal Pain Management NYC, 369 Lexington Avenue (Midtown Manhattan, 10017). Same-week appointments are typically available. Insurance generally does not cover this therapy. We go over what your plan covers and any expected cost by phone before your visit, so there are no surprise bills. Call (646) 290-6660 or book online to schedule your consultation.
What the evidence shows
The honest split here is between the drug and the antioxidants. The ketorolac (Toradol) in this infusion is a genuine anti-inflammatory, an NSAID with a well-documented effect on inflammatory pain and swelling. That part is not in question, and it is the reason the infusion works as an anti-inflammatory.
The vitamin C and glutathione are a different story. They are reasonable antioxidants, but the claim that IV vitamin C meaningfully reduces systemic inflammation has not held up in controlled human trials. One large test came in a very different population. In 501 patients with sepsis, IV vitamin C given with thiamine and hydrocortisone did not increase days alive without a ventilator or blood-pressure drugs compared with placebo (Sevransky et al., 2021). No trial has tested these antioxidants for chronic pain flares. We include them for their antioxidant and supportive role, not as proven anti-inflammatories, and Dr. Movshis reviews your history before any infusion.